Data updated: Sep 20, 2026
Ticovac (tick-borne encephalitis vaccine) · Pfizer
Approved 2021-08-12
1
Indication
--
Phase 3 Trials
5
Years on Market
Details
- Status
- Prescription
- First Approved
- 2021-08-12
- Revenue
- $132M (Q2-2026)
- Routes
- Intramuscular
- Dosage Forms
- Injection
Companies
Website: ↗
Ticovac Approval History
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
1 FDA actions from 2021 to 2021
Aug 2021 ORIGINAL
Update · CBER biologic (Purple Book)
What Ticovac Treats
1 FDA approvalsOriginally approved for its first indication in 2021 .
- Other (1)
Other
(1 approval)- • Approved indication (Aug 2021)
Pfizer's other novel FDA approvals
Other CDER-designated drugs from the same sponsor (2016–2025).
HYMPAVZI
2024 MARSTACIMAB-HNCQ
2 designations
LITFULO
2023 RITLECITINIB TOSYLATE
PAXLOVID (COPACKAGED)
2023 NIRMATRELVIR
3 designations
ELREXFIO
2023 ELRANATAMAB
5 designations
NGENLA
2023 SOMATROGON-GHLA
1 designation
ZAVZPRET
2023 ZAVEGEPANT HYDROCHLORIDE
VELSIPITY
2023 ETRASIMOD ARGININE
CIBINQO
2022 ABROCITINIB
2 designations
NURTEC ODT
2020 RIMEGEPANT SULFATE
VIZIMPRO
2018 DACOMITINIB
2 designations
TALZENNA
2018 TALAZOPARIB TOSYLATE
1 designation
LORBRENA
2018 LORLATINIB
4 designations
📋
Clinical Trial Registry
1 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT01710189 CRC306 | CRC306 | Ph 4 | completed | Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac |
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
|
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
Ticovac FDA Label Details
Pro Intelligence Preview
Deep insights for Ticovac
Revenue Insights
- • Q2-2026: $132M
- • Historical trend analysis
Patent Timeline
- • Patent expiration dates
- • Generic/biosimilar risk
Trial Analysis
- • Clinical trial tracking
- • Development stage analysis
Competitive Landscape
- • Competitor tracking
- • Same target/indication analysis
Unlock Full Intelligence
Full approval history • All patents • Revenue trends • Competitor analysis
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.